The
U. maydis strains used in this work (
Table S3) derive from the lab strains AB33 [14 (
link)], SG200 [7 (
link)], and SG200-pit1∆ [23 (
link)]. The cells were grown in complete medium (CM: 0.25%
w/v cas-amino acids (Difco), 0.1%
w/v yeast extract (Difco), 1.0%
v/v vitamin solution, and 6.25%
v/v salt solution from Holliday [24 ], 0.05%
w/v deoxyribonucleic acid from herring sperm, and 0.15%
w/v NH
4NO
3 adjusted to pH 7.0 with
NaOH (Sigma Aldrich, Darmstadt, Germany) and supplemented with 1% glucose. The transformation of
U. maydis protoplasts followed the protocol from [25 (
link)]. The constructs were integrated using homologous recombination into the
pep4 or
upp3 locus, and the transformants were selected on the corresponding antibiotics (200 μg/mL
hygromycin, 150 μg/mL
nourseothricin, 2 μg/mL
carboxin (Sigma Aldrich, Darmstadt, Germany)).
For fluorescence analysis with plate readers, the strains were grown overnight in CM-glucose, before shifting the cultures to nitrate minimal medium (NM)-glucose for the induction of filamentous growth in AB33. Hyphal growth was induced by changing the media to nitrate minimal medium (NM) supplemented with 1% glucose or arabinose. All strains were confirmed using Southern blot analysis [8 (
link)] or genotyping PCR.
Heucken N., Tang K., Hüsemann L., Heßler N., Müntjes K., Feldbrügge M., Göhre V, & Zurbriggen M.D. (2023). Engineering and Implementation of Synthetic Molecular Tools in the Basidiomycete Fungus Ustilago maydis. Journal of Fungi, 9(4), 480.